PMWC Blog

Honoring leaders of CRISPR, Telomere, Genomics England, Antibody-Based Drugs, and Genomics Methodologies at PMWC 2018 Silicon Valley

Each plays a critical role in shaping the human healthcare system, moving it from a general population approach toward a personalized and patient-centered care model. For this reason, we will honor these leaders for their outstanding contributions to medicine with either a Pioneer or Luminary Award

Read More

Note from Dr. Eric Schadt, PMWC 2018 SV AI Track Chair

Artificial Intelligence and machine learning are on everyones’ minds these days, and they are poised to become game changers in many areas, including the healthcare sector. There’s a rise in potential applications and companies developing new approaches and innovative tools and the industry is responding

Read More

PMWC Interview with Slava Akmaev, Ph.D., SVP & Chief Analytics Officer, Berg

We had a chance to sit down with Dr. Slava Akmaev – who will be speaking at our upcoming PMWC 2018 Silicon Valley conference this coming January – to discuss his vision of “why data-driven research is important, and how machine learning and AI will...
Read More

Note from Dr. Ira Mellman, PMWC 2018 SV Immunotherapy Track Chair

Immunotherapy has evolved rapidly from first promising clinical results to nothing short of revolutionizing therapy in various cancer indications. On almost a daily basis do we learn about progress in both single and combination therapies for not only disease management but lasting remissions and even cures. Despite these successes

Read More

Note from Dr. George Sledge, PMWC 2018 SV Program Chair

Dear Colleagues, Over the past few years, we have seen major advancements in oncology propelled by increasing molecular and cellular mechanistic insights and applications of Precision Medicine. Tailored treatment for BRCA-positive mutation carriers and breast cancer...
Read More

Q&A with Elizabeth Blackburn (2009 Nobel laureate), PMWC 2018 SV Honoree

We had a chance to sit down with Dr. Elizabeth Blackburn to discuss telomeres and telomerase and their impact on the human lifespan. To learn more about the different AI and machine learning sessions planned for PMWC 2018 SV, see the full agenda here. Q: Your research...
Read More

Interview with Edward S. Kim Chair, Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute

Kim, you are the chair of Solid Tumor Oncology and Investigational Therapeutics and the Donald S. Kim distinguished chair for cancer research at the Levine Cancer Institute, Carolinas HealthCare System in Charlotte, NC. Q: What are some of the activities of the Levine...
Read More

Next Proposed “Big Science” Project Focuses on Pre-Cancer

PMWC will focus on understanding the tipping point of cancer at its upcoming conference Cancer prevention is the holy grail of cancer elimination. It’s apparent now, that making this concept a reality will require a deep understanding of the molecular events that lead...
Read More

Chris Callahan, GeneInsight: Interview Q&A

Q: There are many solutions available in support of the molecular and genetics testing labs workflow. What are some of biggest challenges molecular and genetic testing labs have to overcome? A: Currently, labs are really struggling to find a way forward as the...
Read More

NIH Director Dr. Francis Collins Discusses the All of Us Initiative and NIH Funding with PMWC

Dr. Francis S. Collins, Director of the NIH has advised President Obama on prominent health initiatives, such as the BRAIN and Cancer Moonshot initiatives and the Precision Medicine Initiative. He also played a vital role in the multibillion-dollar effort to sequence...
Read More
University of Michigan

About us:
The Precision Medicine World Conference (PMWC), in its 13th installment, will take place in Silicon Valley on January 22-24, 2018. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.

Agenda highlights:

    • More than 70 sessions with 250+ thought-provoking, insightful talks that cover all facets of precision medicine
    • Four tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
    • Immuno-oncology
    • Cancer and rare disease diagnostics
    • Biomarker and companion diagnostics
    • Big data approaches
    • NGS applications
    • AI and machine learning applications
    • Advancements in liquid biopsy applications
    • Wellness & Aging
    • CRISPR
    • The human microbiome
    • Infectious disease ID and monitoring
    • The importance of patient engagement
    • 3-D technologies
    • Updates on data and regulatory policies
    • Metabolomics in precision medicine
    • mHealth and Telehealth

About us:
The Precision Medicine World Conference (PMWC), in its 13th installment, will take place in Silicon Valley on January 22-24, 2018. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.

Agenda highlights:

    • More than 70 sessions with 250+ thought-provoking, insightful talks that cover all facets of precision medicine
    • Four tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
        • Immuno-oncology
        • Cancer and rare disease diagnostics
        • Biomarker and companion diagnostics
        • Big data approaches
        • NGS applications
        • AI and machine learning applications
        • Advancements in liquid biopsy applications
        • Wellness & Aging
        • CRISPR
        • The human microbiome
        • Infectious disease identification and monitoring
        • The importance of patient engagement
        • 3-D technologies
        • Updates on data and regulatory policies
        • Metabolomics in precision medicine
        • mHealth and Telehealth

One track will be dedicated to the various aspects of the All of Us Research Program, while another session will focus on educating California’s legislators.

 

Confirmed thought leaders include:

Sir John Bell

Sir John Bell

Regius Professor of Medicine, Oxford University

sally-davies

Dame Sally Davies

Chief Medical Officer, Department of Health, UK Government

BLA00002-Elizabeth-Blackburn

Elizabeth Blackburn

Nobel Laureate, President, Salk Institute for Biological Studies

George-Sledge

George Sledge

Professor, Division Chief, Stanford University Medical Center

Jeffrey Bluestone

Jeffrey Bluestone

CEO and President, Parker Institute for Cancer Immunotherapy

Christopher Ianelli

Christopher Ianelli

Founder and Chief Executive Officer,  iSpecimen

Kenneth J. Pienta

Kenneth J. Pienta

Director, Brady Urological Institute, Johns Hopkins Medicine

Roy Beveridge

Roy Beveridge

Senior Vice President & Chief Medical Officer, Humana

Kimberly Blackwell

Kimberly Blackwell

Professor of Medicine, Assistant Prof. of Radiation Oncology, Duke Cancer Institute

Joshua Denny

Joshua Denny

Professor of Biomedical Informatics & Medicine, Vanderbilt University Medical Center

Edward S. Kim

Edward S. Kim

Chair, Solid Tumor and Investigational Therapeutics, Levine Cancer Institute

Howard L. McLeod

Howard L. McLeod

Medical Director, Personalized Medicine Institute, Moffitt Cancer Center

Lee Newcomer

Lee Newcomer

SVP, UnitedHealthcare Oncology and Genetics

Vinod Khosla

Vinod Khosla

Partner and Founder of Khosla Ventures

Troy Brennan

Troy Brennan

Executive VP & CMO, CVS Health

Ira Mellman

Ira Mellman

VP, Cancer Immunology, Genentech

Event Highlights

When
January 22, 2018 8:00am to January 24, 2018 5:00pm
Where
Computer History Museum
1401 N Shoreline Blvd
Mountain View, CA 94043
Cost
$1150 by October 31st, 2017
Registration
3-Day Access to Talks, Exhibition & Reception:
See Registration Details

Registration: PMWC Conferences

Silicon Valley Jan 22-24, 2018

65+ Sessions 4 Tracks
250+ Speaker lineup
Access to the exhibition
Breakfast & lunch refreshments
Networking App
Award Reception

Having Trouble Registering? We accept all major credit cards. Select 'PayPal Check out' and press 'Pay with Debit or Credit Card'.
Click here or call (650)-961-8877 to contact the PMWC Team for Help.